Massivemarkets

BLSM

BlossomHill Therapeutics, Inc. Common Stock

Nasdaq · usd

$14.59-0.54 (-3.57%)
As of 4:40:11 PM EST on Nov 18, 2026 · 15-minute delayed

BlossomHill Therapeutics, Inc. Common Stock (BLSM) trades at $14.59 (-3.57%) as of 4:40:11 PM EST on Nov 18, 2026, +1.32% over the past month. Market cap is $463.74M, with 4.7 days to cover in short interest.

Stock performance

How BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock has performed from one day to one year, with its 52-week range.

-3.57%
-$0.54 over 1D
$14.55$15.13$15.71$16.299:30 AM11:05 AM12:50 PM2:35 PM8:00 PM$14.59
1D
-3.57%
1W
-9.49%
1M
+1.32%
YTD
-8.81%
1Y
-8.81%
52-wk range
$11.02 – $27.99

Key statistics

Today's trading snapshot for BLSM: day range, open, previous close, volume and market cap.

Day range
$14.34 – $16.75
Open
$15.17
Prev close
$15.13
Volume
280.17K
Market cap
$463.74M
Shares out
31.78M

8-K filings

Material corporate events BlossomHill Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • Quarterly earningsSep 18, 2026

    On September 18, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.

  • On September 15, 2026, BlossomHill Therapeutics, Inc. issued a press release announcing updated data from the ongoing Phase 1/2 SOLARA trial of BH-30643 in non-small cell lung cancer (NSCLC) patients with secondary epidermal growth factor receptor (EGFR) resistance mutations such as EGFR C797S.

  • Public offeringAug 10, 2026

    On August 10, 2026, the Company completed its IPO of an aggregate of 9,375,000 shares of common stock at a price to the public of $16.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $150.0 million.

Dividend history and stock splits

BlossomHill Therapeutics, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 55-for-1Mar 16, 2006

BLSM short interest

How heavily BLSM is shorted: shares short, days to cover and average daily volume.

Days to cover
4.7
Short interest
590.13K
Avg volume
126.89K

As of · reported to FINRA twice monthly.

Frequently asked questions

What is the BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock price today?

BlossomHill Therapeutics, Inc. Common Stock (BLSM) is trading at $14.59 (-3.57% on the day) as of 4:40:11 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is BlossomHill Therapeutics, Inc. Common Stock?

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment.

What is the short interest in BLSM?

As of Oct 30, 2026, BLSM has 590.13K shares short and 4.7 days to cover.

What exchange is BLSM listed on?

BlossomHill Therapeutics, Inc. Common Stock (BLSM) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of BLSM with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BLSM analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.